ZOMP
PrivateLast Round
Seed
May 30, 2023
Total Funding Raised
$2.48M
Momentum Score
25 /100
Company Overview
ZOMP is a life sciences company developing a 3D imaging flow cytometer to analyze and sort cells for applications in immunotherapy, drug discovery, and cancer diagnosis.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Drug Discovery, Biotechnology, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ZOMP Comps
Public and private peers based on sector, stage, and business model.
ZOMP Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 30, 2023 |
Key People
Founding team and executive leadership
ZOMP Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BGF | Seed |
| Cambridge Enterprise | Seed |
| Foresight Williams Technology | Seed |
| ZEISS Ventures | Seed |
ZOMP Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ZOMP's valuation, stock price, and market status.
